CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-01 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +10,000 | $0.60 | $6K | 12,485 |
| 2024-11-01 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −10,000 | $12.68 | $127K | 2,485 |
| 2024-11-01 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 10,000 | ||
| 2024-10-01 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +10,000 | $0.60 | $6K | 12,485 |
| 2024-10-01 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −10,000 | $12.06 | $121K | 2,485 |
| 2024-10-01 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 20,000 | ||
| 2024-09-19 | Skorpios Trust 10% owner | Sale | −1,937,500 | $14.05 | $27.2M | 8,906,181 |
| 2024-09-03 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +10,000 | $0.60 | $6K | 12,485 |
| 2024-09-03 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −9,400 | $14.92 | $140K | 3,085 |
| 2024-09-03 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −600 | $15.41 | $9K | 2,485 |
| 2024-09-03 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 30,000 | ||
| 2024-08-01 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +10,000 | $0.60 | $6K | 12,485 |
| 2024-08-01 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −10,000 | $14.58 | $146K | 2,485 |
| 2024-08-01 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 40,000 | ||
| 2024-07-02 | Nash Huw M. Chief Business Officer | Sale 10b5-1 | −2,467 | $13.10 | $32K | 33 |
| 2024-07-02 | Nash Huw M. Chief Business Officer | Sale 10b5-1 | −33 | $13.90 | $459 | 0 |
| 2024-07-01 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +10,000 | $0.60 | $6K | 12,485 |
| 2024-07-01 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −10,000 | $13.75 | $137K | 2,485 |
| 2024-07-01 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 50,000 | ||
| 2024-06-05 | Harrison Seth Loring Director | Grant or award · Director Stock Option (Right to Buy) | +7,639 | 7,639 |
Page 15 of 24 · 461 trades